DeutschNewstral
Article
The Salt Lake Tribune on 2016-11-23 17:33
Juno Therapeutics halts study after patient deaths
Related news
Juno Therapeutics halts study after more patient deathsneworleanscitybusiness.com
Juno Therapeutics halts study after more deathsThe Columbian
Juno Therapeutics halts leukemia study after more patient deaths - Wed, 23 Nov 2016 PSTThe Spokesman-Review- Juno Therapeutics suspends drug trial after new patient deaths - Thu, 24 Nov 2016 PSTThe Spokesman-Review
- MUPDATE: Juno Therapeutics plummets 30% in pre-market trade after two patient deathsmarketwatch.com
FDA suspends Juno clinical trial after 2 patient deathsbizjournals.com
Crisis of the Week: Patient Deaths Flummox Juno Therapeuticsblogs.wsj.com
Juno Therapeutics suspends drug trial after new patient deathsseattletimes.com- Juno Therapeutics to open Bothell manufacturing facilitybizjournals.com
Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient DeathsForbes
Celgene in Talks to Buy Juno Therapeuticswsj.com- Juno Therapeutics Settles Patent Dispute With Novartiswsj.com
- Juno Therapeutics Re-Starts Cancer Trial After Deaths Put Study on HoldForbes
- MJuno Therapeutics plummets as cancer-drug study put on hold after two deathsmarketwatch.com
Hospital system probing 27 patient deathsThe Findlay Courier- Celgene to Buy Juno Therapeutics for $9 Billionwsj.com
Trump administration halts study of offshore oil inspectionsKRQE News 13- Juno being sued over leukemia drug studyseattletimes.com
- TCoronavirus halts student’s study abroadthenews.org
- Investors short Juno Therapeutics, Amgen stocks, but that may not be bad newsbizjournals.com